Advancing personalized medicine through pharmacogenomics: Insights from Ochsner Health
2025-06-02
(Press-News.org) In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the multifaceted implementation of pharmacogenomics—a rapidly evolving field that examines how genetics influence individual responses to medication. This comprehensive article, led by Dr. Catherine Oliver and a team of experts in pharmacy services, provides an insightful blueprint for health systems aiming to integrate pharmacogenomics into clinical practice.
"Pharmacogenomics embodies a new frontier in precision medicine, enabling us to fine-tune treatments to the genetic profiles of individual patients," says Dr. Catherine Oliver, PharmD, BCPS, DPLA, CPGx, and lead author of the study. "Our implementation journey at Ochsner Health underscores the pivotal role pharmacists play in spearheading these personalized healthcare innovations."
The article outlines considerations necessary for establishing a pharmacogenomics service, from patient population targeting and testing strategies to reimbursement challenges and education pathways. Dr. Oliver and the article co-authors emphasize the advantages of pharmacist-driven initiatives in overcoming barriers and maximizing the impact of pharmacogenomics in improving patient outcomes.
As pharmacogenomics continues to gain traction across various medical specialties, this article serves as a valuable resource for physicians, pharmacists, and medical professionals committed to integrating genetic insights into their therapeutic decision-making processes. By sharing the Ochsner Health experience, Dr. Oliver and team provide a practical framework that can be adapted to other healthcare settings, potentially transforming patient care through personalized medicine.
###
About Ochsner Health
Ochsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 13 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for four consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and digital connectivity not found anywhere else in the region. In 2024, Ochsner Health cared for more than 1.6 million people from every state in the nation and 63 countries. Ochsner’s workforce includes more than 40,000 dedicated team members and over 4,900 employed and affiliated physicians. To learn more about how Ochsner empowers people to get well and stay well, visit https://www.ochsner.org/.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-06-02
Key takeaways
Ibudilast is a drug approved in Japan for the treatment of asthma and post-stroke dizziness by targeting inflammation; previous research suggested it could also help people reduce their drinking.
A UCLA clinical trial, however, has now shown that ibudilast worked no better than a placebo for trial participants in reducing alcohol consumption, although it did have a positive effect on women.
Women tend to have higher levels of inflammation than men, and the results of ibudilast testing with women point toward ...
2025-06-02
Researchers have created dynamic structures that leap into the air on a predetermined schedule without intervention from computers or external stimuli. Precisely when these “metashells” jump, and how high they jump, is engineered into the physical structure of the materials.
“There are structures that ‘jump’ immediately when loading is removed – such as when a coiled spring is released,” says Jie Yin, corresponding author of a paper on the work and an associate professor of mechanical engineering at North Carolina State University. “We wanted to create a structure that does not rely on external stimuli and allows us to dictate the timing ...
2025-06-02
Along with nutrients like nitrogen and phosphorus, iron is essential for the growth of microscopic phytoplankton in the ocean. However, a new study led by oceanographers at the University of Hawai‘i (UH) at Mānoa revealed that iron released from industrial processes, such as coal combustion and steel making, is altering the ecosystem in the North Pacific Transition Zone, a region just north of Hawai‘i that is important for fisheries in the Pacific. The study was published today in the Proceedings of the National Academy of Sciences USA.
“This ...
2025-06-02
Imagine a world where crops can thrive regardless of climate or disease and provide all the essential nutrients our bodies need. Researchers at Western University’s Schulich School of Medicine & Dentistry are now part of a U.K.-based initiative to explore that very possibility.
The Advanced Research + Invention Agency (ARIA), the U.K.’s research and development funding agency, announced June 2 that Schulich Medicine & Dentistry professor Bogumil Karas has been named ...
2025-06-02
CLEVELAND – A new visionary gift from the Veale Foundation will establish the University Hospitals Veale Healthcare Transformation Institute. The $23.5 million in support represents an investment in University Hospitals’ value-based care initiatives. Peter J. Pronovost, MD, PhD, UH Chief Quality and Clinical Transformation Officer, will serve as the institute’s founding and first president.
“Healthcare today tells a story of scarcity – it harms too often, costs too much and learns and ...
2025-06-02
In a new JNeurosci paper, Adrian Rothenfluh and colleagues from the University of Utah developed a fruit fly model of cocaine self-administration that can be used to explore the genetic underpinnings of cocaine addiction.
To model voluntary cocaine intake in fruit flies, or Drosophila melanogaster, the researchers first assessed cocaine consumption and preferences of this insect. Cocaine was innately aversive to fruit flies because it activated their bitter-sensing receptors. In other words, the fruit flies did not like cocaine’s ...
2025-06-02
For the first time, researchers have created genetically modified fruit flies that can become addicted to cocaine. The flies will self-administer cocaine if given the option. The new model could prove immensely valuable for the development of new therapies to prevent and treat cocaine use disorder, a growing and deadly concern that affects about 1.5 million people nationwide.
Heredity strongly impacts the risk of developing cocaine use disorder, but the large number of genes implicated in addiction risk has made it difficult to determine which might be the best targets for therapeutics.
With their new fruit fly model ...
2025-06-02
A new county-level dataset from Johns Hopkins University researchers reveals a national decline in the measles-mumps-rubella (MMR) vaccination rate among U.S. children since the start of the COVID-19 pandemic.
Out of 2,066 studied counties, 1,614 counties, 78%, reported drops in vaccinations and the average county-level vaccination rate fell 93.92% pre-pandemic to 91.26% post-pandemic—an average decline of 2.67%, moving further away from the 95% herd immunity threshold to predict or limit the spread of measles.
Only four of the 33 states in studied—California, ...
2025-06-02
About The Study: In an average-risk colorectal cancer screening population, a blood-based test demonstrated acceptable accuracy for colorectal cancer detection, but detection of advanced precancerous lesions remains a challenge, and ongoing efforts are needed to improve test sensitivity.
Corresponding Author: To contact the corresponding author, Theodore R. Levin, MD, email theodore.levin@kp.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.7515)
Editor’s Note: Please see the article for additional ...
2025-06-02
About The Study: The finding of a slightly lower prevalence of any adenoma in the younger compared with the older age group (35.4% vs 40.8%) in the current study is consistent with an evaluation of 2001 screening colonoscopies from a university-based medical center between 2019 and 2021, which reported slightly lower rates of adenoma detection in those ages 45 to 49 vs 50 to 54 (34.3% vs 38.2%) and with a large study of adenoma detection rates in those ages 45 to 49 vs 50 to 54 (28.6% vs 31.8%) who underwent a screening colonoscopy before the change in guidelines ...
LAST 30 PRESS RELEASES:
[Press-News.org] Advancing personalized medicine through pharmacogenomics: Insights from Ochsner Health
